Chemotaxis is a highly coordinated biological system where chemoattractants trigger multiple signal transduction pathways which act in concert to bring about directed migration. A signaling pathway acting through PIP 3 , which accumulates at the leading edge of the cell, has been extensively characterized. However, chemotaxis still remains in cells depleted of PIP 3 , suggesting there are PIP 3 -independent pathways. We have identified a pathway involving TorC2-PKBR1 as well as another containing PLA2 activity that act in parallel with PIP 3 . Activation of PKBR1, a myristoylated Protein Kinase B homolog, is dependent on TorC2 (Rapamycin-insensitive Tor complex 2) kinase but is completely independent of PIP 3 . In response to chemoattractant, PKBs rapidly phosphorylate at least eight proteins, including Talin B, PI4P 5-kinase, two RasGefs, and a RhoGap. These studies help to link the signaling pathways to specific effectors and provide a more complete understanding of chemotaxis.
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Tian Jin and Dale Hereld (eds.), Chemotaxis, Methods in Molecular Biology, vol. 571 DOI 10.1007/978-1-60761-198-1_17, © Humana Press, a part of Springer Science + Business Media, LLC 2009 255 differentiation, forming a fruiting body which contains spores that resist harsh conditions. The chemotaxis toward cAMP is easily and consistently reproducible under standard laboratory conditions. The following additional features of this organism increase its value as a model system for studies of eukaryotic chemotaxis. With a sequenced 34-Mbp genome size, the organism is genetically and biochemically tractable. For example, gene disruption by homologous recombination, restriction enzyme mediated insertional mutagenesis, and chemical mutagenesis are easily achieved. It is also simple and convenient to generate up to 3 × 10 11 cells in suspension culture for biochemical assay and protein purification.
Accumulated evidence now indicates that a network of signaling pathways contribute to efficient chemotaxis (1-3) (Fig. 1) . Chemoattractant binds to G-protein-coupled receptors uniformly distributed around the cell's periphery and cause activation of the heterotrimeric G-protein consisting of Ga2 and Gbg. This activation leads to a rapid, and in most cases, transient burst of responses such as production of the second messengers PIP 3 , cGMP, and cAMP. PIP 3 accumulates locally at the front of cells by the Fig. 1 . Model of chemoattractant signaling pathways in Dictyostelium discoideum. The chemoattractant, cAMP, binds to the cAR1 and activates the heterotrimeric G-protein. The activation conveys signals via multiple pathways to successfully achieve chemotaxis. The indicated Ras proteins thought to be locally activated at the front of cells are suggested to regulate PI3K and TorC2 activities. PIP 3 production resulting from the countered reactions of PI3K and PTEN causes the recruitment of PH domain containing proteins, PhdA, Crac, and PKBA. Pla2 activity is required for the actin polymerization in parallel with PIP 3 pathway. TorC2 organizes the cAMP information through PKB and other undefined activities. PKB activity is composed of PKBR1, a more predominant activity and completely dependent on TorC2 for activation, and PKBA, a minor activity dependent on recruitment to PIP 3 and TorC2 (heavier or lighter arrows). Together these phosphorylate several substrates, for example, Talin B (TalB), RasGEFS (GefS), RasGEFN (GefN), PI5K, and Rho GAPQ (GacQ). 
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Effector opposing actions of PI 3-kinase and PTEN which reversibly convert PI (4, 5) P2 to PI (3.4.5) P3. The information conveyed by the elevated PIP 3 is transmitted by recruitment of proteins containing PIP 3 -specific PH (Pleckstrin homology) domains such as CRAC (4), PhdA (5), and PKBA (6). Although misregulation of PIP 3 , as occurs in cells lacking PTEN greatly impairs chemotaxis (7), PI 3-kinase activity is not essential for chemotaxis (8).
The search for PIP 3 -independent pathways has led to the isolation of PLA2 activity as an enhancer of PIP 3 -dependent chemotaxis (9). PLA2 activity appears to contribute to cell motility by regulating actin polymerization in parallel with PIP 3 .
Recently, we have shown that the TorC2-PKBR1 pathway plays an important role in chemotaxis and is independent of PIP 3 (10). D. discoideum has two PKB (Protein Kinase B) homologs, PKBA and PKBR1 (6, 11). Both proteins are structurally very similar to the mammalian PKBs, except for the membrane-binding domain at N-terminus. Like the mammalian enzymes, PKBA has a PIP 3 -specific PH domain which functions to recruit it to membrane-associated PIP 3 , while the myristoylated PKBR1 is evenly distributed on the membrane. These proteins require specific phosphorylations in the activation loop and in the hydrophobic motif for the full activity. A commercial antibody specific for the phosphorylated state of PKB substrates in vivo has provided evidence that PKBR1 is the major PKB activity and that PKBA makes a minor contribution. PiaA (pianissimoA), originally isolated in a forward genetic screen for chemotaxis and early development defects, is now recognized to be a subunit of TorC2 kinase (12, 13). Work in Drosophila and mammalian cells identified TorC2 as the kinase responsible for the phosphorylation of the hydrophobic motif of PKB (14). Consistent with this, the activity of PKBR1 depends on TorC2 phosphorylation of its hydrophobic motif. The TorC2-PKBR1 pathway is insensitive to PIP 3 depletion and is selectively activated at the cell's leading edge. The PIP 3 -independent PKBR1 and PIP 3 -dependent PKBA pathways converge with their overlapping substrates, including TalinB, RasGEFs, RhoGAP, PI5K, and others (10). Work is currently focused on determining which substrates are involved in signaling and cytoskeletal regulation for proper chemotaxis. ) and 5 mL of 20 mM PIPES Buffer (pH 6.0) in a 50-mL disposable tube, microwave in brief pulses until dissolved, and then cool quickly on ice to room temperature. Finally add 3.25 mL H 2 O, 0.25 mL 2.5 M sucrose, and then 1.5 mL saturated picric acid solution (Fluka).
4.
Quenching solution. 100 mM glycine in PBS.
PBS (Phosphate-buffered saline)
. 137 mM NaCl, 2.7 mM KCl, 10 mM Na 2 HPO 4 , 1.8 mM KH 2 PO 4 (pH 7.4).
6. Blocking solution. 2% (w/v) BSA in TBS-TX100.
TBS-TX100 (Tris-buffered saline with Triton X100). 20 mM
Tris-HCl of pH 7.5, 137 mM NaCl, 0.1% Triton X100. 1. 2× NP-40 lysis buffer. 80 mM HEPES (pH 7.5), 100 mM NaF, 4 mM Na 3 VO 4 , 50 mM sodium pyrophosphate, 1% NP-40, 2× protease inhibitor complete EDTA free (Roche, Manheim, Germany), 2% protease inhibitor cocktail (Sigma Aldrich, St. Louis, MO).
2. Protein G-Sepharose (GE-Healthcare); wash twice with PBS containing 5 mg/mL BSA before use.
3. Antibody. Antiphospho PKB substrate antibody (Cell Signaling Technology).
4. 1× RIPA buffer. Tris-HCl of pH 8.0, 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 1× protease inhibitor complete EDTA free (Roche), 1% protease inhibitor cocktail (Sigma Aldrich).
5. 150 × 25 mm of tissue culture dish from (Becton Dickinson).
Indirect Immunofluorescence

Immunopurification of PKB Substrates
1. Nucleopore Track-Etch membrane, 5 mm pore size (Whatman).
Syringes for cell lysis.
For each, fold a Nucleopore membrane in half and place it between the needle and barrel of a 1-mL disposable syringe.
All genes referred to in these protocols are listed in Table 1 together with their DDB numbers, which can be used to search dictybase (http:// www.dictybase.org) to access a knowledge base for each gene, including sequence information, expression properties, relevant literature, and available resources.
D. discoideum shows reliable chemotaxis to cAMP at the early development stage, after 5-h starvation. These cells are typically used for chemotaxis analysis. This section describes the method for preparing the cells.
1. Culture axenically in HL5 medium at 22°C to a density of less than 5 × 10 6 cells/mL. This section describes a method to assess cell aggregation in response to starvation with or without an inhibitor, such as LY294002 (see Note 7). This aggregation process includes chemotaxis and other cellular events. The method can also be applied to assess the defect in a mutant cell line. Table 1 Genes and DDB (Dictyostelium Data Base) numbers 5. Incubate at 22°C for about 18 h to form aggregates.
6. Take a picture using a dissection microscope (see Fig. 2a ). This section describes two different methods to evaluate chemotaxis. These two methods are not necessarily identical in the degree of chemotaxis activity. It might be important to carry out several different assays to document subtle defects.
1. Dilute competent cells to around 1-4 × 10 5 cells/mL in DB.
2. Disperse cells by pipetting several times or vortexing weakly.
3. Spot 20 mL on a chamber cover glass.
4. Wait for 10-15 min for cells to adhere; then gently add 3 mL of DB.
5. Load a Femtotip microinjection needle with 10 mM cAMP, connect the needle to a microinjector, lower the needle to touch the coverslip using a micromanipulator, and apply positive pressure (25 psi) with the microinjector.
6. Take photographs at 30-s intervals for 30 min (see Note 8) (see Fig. 2b ).
1. Pour 10 ml of 1% melted agar in a 90-mm Petri dish 1 h before assay (see Note 9).
2. Dilute competent cells to about 1 × 10 6 cells/mL in DB. This section describes the detection of PIP 3 products, the output of the PI3K pathway, by imaging and by biochemical analysis. A PIP 3 -specific PH domain from either CRAC or PKBA is typically used as a biosensor.
PIP 3 production following addition of uniform chemoattractant or spatial localization in cells under a variety of conditions is detected by one of the PIP 3 -specific PH domain fused with a fluorescent protein (6, 7). 1. Starve cells expressing this biosensor to chemotactic competence and uniformly stimulated with cAMP at a final concentration of 1 mM.
Capture images at 2-s intervals for 1-2 min.
Chemotaxis Assays
Micropipette Assay
Two-Drop Assay
Detection of PIP 3 Production
PIP 3 Detection by a Biosensor, PH-GFP (Fluorescent Microscope)
3. To visualize the localized accumulation of PIP 3 , cells are placed on the chamber coverslip and observed under fluorescence microscope doing chemotaxis toward spontaneously secreted cAMP or toward a gradient from a micropipette.
1. Starve cells expressing PH-GFP at 2 × 10 7 cells/mL in 5 mL and basalate with caffeine as described in Subheading 3.1.1. 6. Transfer into a 1-mL of disposable syringe containing 100 mL of basal buffer and lyse through 5-mm membrane into a microcentrifuge tube containing 1 mL PM on ice.
Wash cells with
7. Microcentrifuge at full speed for 1 min at 4°C and aspirate the supernatant.
8. Suspend the pellet in 50 mL of 1× SDS sample buffer and boil them for 5 min.
9. Run SDS PAGE followed by western blotting with a-GFP antibody as a primary antibody.
This section describes methods to biochemically and cytologically assess PKB and TorC2 activity using the following phospho-specific antibodies. First, a phospho PKB substrate antibody used to detect the phosphorylated state of pp350, pp200, pp180 (GefS), pp110 (GefN and PI5K), and pp65/67 (GacQ) and other substrates of PKB. Second, a phospho PDK docking motif antibody used to detect the phosphorylated state of the hydrophobic motif of PKBR1 (T470). For PKBR1 the extent of this phosphorylation correlates strongly with the activation state of TorC2. Third, a phospho PKC (pan) antibody used to detect the phosphorylation state of the activation loops of PKBR1 (T309) and PKBA (T278). Evidence from other model systems suggests that these phosphorylations would be catalyzed by a PDK homolog and essential for their activities. Two PDK homologs are present in D. discoideum. Fourth, antiphospho AKT (S473) can be used to detect activation of TorC2 in cells expressing a chimeric protein where the PH domain of human AKT is replaced with the myristoylated N-terminal of PKBR1.
1. Transfer 0.5-mL competent cells on ice (see Note 12) at a density of 2 × 10 7 cells/mL to a 5-mL disposable plastic beaker shaking at 150 rpm (see Note 13). Within 2 min, add 100 mM of cAMP to final concentration of 1 mM. 3. To transfer proteins to a PVDF membrane, place a pad and two sheets of 3-MM paper wetted with the transfer buffer on the black (cathode -) side of the cassette holder. Place the gel on the 3-MM paper and lay the PVDF membrane on top of it. Remove bubbles between the gel and the PVDF and put two more sheets of 3-MM paper and a pad.
4. Place the sandwich into the transfer tank such that the PVDF membrane is between the gel and the anode (+) and fill the cold transfer buffer.
5. Turn on the system for 80 min at 75 mV in the cold room.
6. After the transfer, rinse the PVDF membrane with TBST twice quickly.
7. Incubate the membrane in 50 ml of blocking buffer for 1 h at room temperature.
8. Discard the blocking buffer and rinse the membrane with TBST twice quickly.
9. Incubate the membrane with a primary antibody at 4°C overnight.
10. Remove the primary antibody, rinse the membrane with TBST twice quickly, and further wash with TBST for 10 min, 5 min, and 5 min at room temperature.
11. Incubate the membrane with a secondary antibody for 1 h at room temperature.
12. Remove the secondary antibody, rinse the membrane with TBST twice quickly, followed by one 10 min and four 5 min washes with TBST at room temperature.
13. Prepare the ECL reagent and incubate the membrane with it for 1 min.
14. Remove the ECL reagent and wrap the membrane with plastic wrap.
15. Expose the membrane to X-ray film in the cassette for a suitable time.
Western Blotting
16. To confirm the loading of proteins, stain the membrane in CBB solution for couple of minutes and destain it in 50% methanol for suitable time, typically a few minutes. Place the membrane on a bench to let it dry at room temperature. As shown in Fig. 3a , the phospho PKB substrate antibody stains few bands in competent cells prior to addition of cAMP. Following cAMP stimulation, about ten prominent bands rapidly . These bands reappear when the appropriate proteins are expressed in the null mutants. A few of the bands (pp250, pp30, and pp23) are not dependent on PKB activity and are presumably substrates for other kinases with the consensus motif RXRXXS/T.
As shown in Fig. 3b, c , the phospho PDK docking motif antibody, very specifically detects the phosphorylation state of the hydrophobic motif of the PKBR1. This phosphorylation is completely absent in competent cells prior to stimulation. Following addition of cAMP, it increases rapidly, peaks at 30 s, and disappears within 2 min. This phosphorylation is completely absent in cells lacking PiaA and substantially decreased in cells lacking Rip3 (data not shown), indicating that it is a TorC2 substrate.
As shown in Fig.3c , the phospho PKC (pan) antibody specifically detects the activation loop phosphorylations of PKBA and PKBR1. The time courses of these phosphorylations closely follow those of the hydrophobic motif (see Fig.  3c ). The phosphorylation of PKBA (T278) is abolished in cells lacking PIP 3 production such as pi3k1 − /5 − cells (see Fig. 3d ) and substantially reduced in piaA − cells (see Fig. 3c ). Interestingly, however, the phosphorylation of PKBR1 (T309) is unaffected by the absence of PIP 3 (see Fig. 3d ). It does absolutely require a prerequisite phosphorylation at T470 since T309 is not phosphorylated in T470A versions of PKBR1 or in piaA − cells (see Fig. 3c ). These observations show that the activation of PKBR1 (T309) depends on TorC2 and not PIP 3 , while activation of PKBA (T278) depends on both TorC2 and PIP 3 . This blotting with the activation loop antibody can be used on any cell line to rapidly assess activation of TorC2 as well as PI3K. The antibody is also effective in detecting TorC2 activity cytologically in cells overexpressing PKBR1.
1. Place 18-mm coverslips on parafilm.
Put 5 × 10
5 competent cells expressing R1-AKT-HA in 500 mL DB on the coverslip and allow cells to initiate chemotaxis for 20-30 min at room temperature.
3. Place 500 mL fix solution on the parafilm and transfer the coverslip into this solution followed by 30-min incubation at room temperature.
4. Transfer the coverslip into 500 mL of quenching solution on the parafilm followed by 10-min incubation at room temperature.
5. Wash the coverslip with PBS twice.
Indirect Immunofluorescence
6. Permeabilize and block cells by incubation in the blocking solution for 30 min at room temperature.
7. Remove the blocking solution and place the coverslip cells facing down on 100 mL of the primary antibody solution, either anti Phospho AKT(S473) or anti HA, on the parafilm followed by overnight incubation in the moist chamber at 4°C.
8. Wash the coverslip in 3 mL of TBS using 6-well plate for 5 min three times.
9. Incubate with 100 mL of the secondary antibody (as was done for the primary antibody step) for 1 h at room temperature in the dark.
10. Wash the coverslip in 3 mL of TBS using 6-well plate for 5 min three times.
11. Dip the coverslip once in deionized water.
12. Invert the coverslip cells attached side down and put into a drop of mounting medium on a slide glass (see Note 14).
13. Observe the sample under the fluorescence microscope by excitation at 543 nm. (see Fig. 3e ) The TorC2-PKBR1 pathway is selectively activated at the leading edge of chemotaxing cells. The R1-AKT-HA chimeric protein, where the PH domain of human AKT is replaced with N-terminus PKBR1 containing the myristoylation site, is phosphorylated at S473 in the hydrophobic motif in response to cAMP stimulation. This response is completely dependent on TorC2 activity and does not occur in cells lacking PiaA. As shown in Fig. 3e , indirect immunofluorescence of a cell expressing the R1-AKT-HA by antiphospho AKT(S473) antibody can be used to visualize the activation of TorC2 cytologically. Prior to stimulation there is little or no staining of cells. In highly polarized cells the staining is found selectively at the leading edge.
This section describes the purification of PKB substrates. 4. Centrifuge the cell extracts for 5 min at full speed in microcentrifuge at 4°C.
5.
Transfer the supernatant to a new microcentrifuge tube.
6. Incubate the supernatant with prewashed protein G-Sepharose (see Subheading 2.7, item 2) for 1 h at 4°C.
Purification of Substrates of PKB
7. Centrifuge at 500 × g for 1 min and transfer the supernatant into a new microcentrifuge tube.
8. Add antiphospho PKB substrate antibody (110B7) (1% volume of total cell extracts) and incubate it overnight at 4°C.
9. Add prewashed protein G-Sepharose and incubate for further 1 h at 4°C.
10. Centrifuge at 500 × g for 1 min and wash the beads with 1× NP-40 buffer four times (twice quickly and twice for 15 min).
11. Repeat step 10 using 1× RIPA buffer.
12. Elute the proteins by boiling beads in 1× SDS sample buffer.
13. Separate proteins by SDS-PAGE on 18-well precast gels.
14. Visualize proteins by silver staining (Silver Quest Silverstaining Kit; Invitrogen) in a 150 × 25 mm of tissue culture dish.
1. Antibiotics, such as streptomycin, may be added to prevent contamination.
2. Noble agar can be substituted for hydrophobic agar used in the original protocol (15).
3. The PVDF membrane is quickly prewetted with 100% methanol followed by 2-min soak in H 2 O and equilibrated for at least 5 min in the transfer buffer.
4. For AX3 strains, 20 mg/mL of G418 is used.
5. Fixative solution should be prepared freshly.
6. Measure in the hood. Do not inhale.
7. LY294002 is dissolved in DMSO (Dimethyl sulfoxide). Since DMSO affects cell differentiation, the comparable concentration of DMSO is used as a control.
8. For a large field, a 10× phase objective lens is used.
9. Do not dry the plate too much; otherwise, a droplet cannot be maintained during assay.
10. Score at least eight spots per test concentration.
11. Take duplicate 0-s samples for basal activity.
12. If cells are not maintained on ice, they spontaneously secrete and respond to cAMP within 7 min.
13. A styrofoam rack for 50-mL tubes makes a convenient holder of multiple beakers.
